HALO logo
halo search icon
Aytu BioPharma, Inc.

US$2.15

Price Change Indicator
0.07 (3.36%)
Aytu BioPharma, Inc.
AYTU · NAS

Aytu BioPharma, Inc.

Start Trading AYTU for Free

US$2.15

Price Arrow0.07 (3.36%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHammer BullishHammer Bullish (Realtime)Near Support+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Aytu BioPharma, Inc. Overview

AYTU Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About AYTU

icon
icon

Telephone

1.720.437.6580

icon

Address

Suite 920, 7900 East Union Avenue, Denver, CO 80237

Description

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Denver, CO.

AYTU Price Chart

Key Stats

Market Cap

US$22.33M

PE

7.40

EV/EBITDA

0.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.46 - 3.07

Trade Value (12mth)

US$90,102.00

1 week

-5.02%

1 month

-17.46%

YTD

-24.91%

1 year

2.97%

All time high

11803900.00

Key Fundamentals

EPS 3 yr Growth

-99.90%

EBITDA Margin

11.90%

Operating Cashflow

-$2m

Free Cash Flow Return

-5.50%

ROIC

-40.50%

Interest Coverage

2.10

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

11m

HALO Sector

Healthcare

Next Company Report Date

29-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AYTU Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
03 April 26

AYTU Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5.11-2.86-2.16locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5.11-2.86-2.16locklocklock
Growth
 %locklocklocklock99.74424.5locklocklock
PE
 XlocklocklocklockN/AN/A7.4locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A0.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The current share price of Aytu BioPharma, Inc. (AYTU:NAS) is USD$2.15.
What is the 52-week high share price for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The 52-week high share price for Aytu BioPharma, Inc. (AYTU:NAS) is USD$3.07.
What is the 52-week low share price for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The 52-week low share price for Aytu BioPharma, Inc. (AYTU:NAS) is USD$1.46.
What is the dividend yield for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) does not pay a dividend.
What was Aytu BioPharma, Inc. (AYTU:NAS) last dividend payment?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) does not pay a dividend.
What is the franking level for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) has a franking level of 0.00%.
In which sector is Aytu BioPharma, Inc. (AYTU:NAS) classified?
Halo FAQ
Aytu BioPharma, Inc. (AYTU:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Aytu BioPharma, Inc. (AYTU:NAS)?
Halo FAQ
The current P/E ratio for Aytu BioPharma, Inc. (AYTU:NAS) is 7.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial